top of page

CDC recommends third primary COVID-19 shot for immunocompromised patients

Immunocompromised patients should receive a three-shot COVID-19 primary vaccine series, says the U.S. Center for Disease Control and Prevention (C.D.C.). Those eligible for the three-dose series are at least five years old and have a “moderate to severely weakened immune system.” Such conditions exist if the patient has…

  • Undergone treatments, such as chemotherapy, for tumors or cancers of the blood;

  • Received an organ or stem cell transplant;

  • Immunodeficiency conditions, such as H.I.V., A.I.D.S., DiGeorge syndrome, Wiskott-Aldrich syndrome; or

  • Treatments with high-dose corticosteroids or other drugs that suppress an immune response.

The third dose should be administered at least 28 days after the second shot. Anyone at least 12-year-olds is advised to schedule a single-dose booster shot at least 28 days after completing their primary series. C.D.C. has upheld its preference for the mRNA vaccines manufactured by Pfizer-BioNTech or Moderna because of their higher efficacy rates. The Illinois Public Health Association encourages anyone needing a vaccine or booster to contact their local public health department or visit to find a nearby appointment.

Morreale Communications


bottom of page